Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Prostatic Neoplasms 2 Neoplasm, Residual 2 Lymphoma 2 Esophageal Stenosis 2 Prostate Cancer Metastatic 1 Polycystic Ovary Syndrome 1 Myasthenia Gravis 1 Metastatic Castration-Resistant Prostate Cancer 1 Mediastinal Neoplasms 1 Lymphoma, Large-Cell, Anaplastic 1 Infertility 1 Hodgkin Disease 1 Hemangioma 1 Esophageal Neoplasms 1 Burkitt Lymphoma 1 Barrett Esophagus 1 Adrenal Insufficiency 1

Interventions

ravulizumab 1 Prednisone 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Adrenal Insufficiency × Prednisolone × Clear all

NCT07221838 2026-04-09

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡